REMS & RMP Support
A REMS (Risk Evaluation and Mitigation Strategy) or RMP (Risk Management Plan) is a critical safety program mandated by regulatory authorities to manage the risks associated with specific medications.

These programs ensure that patient access to necessary drugs while minimizing potential harm. REMS or RMP focuses on preventing, monitoring, and managing a specific serious risk by informing, educating, and reinforcing actions to reduce the likelihood and severity of adverse events. These programs reinforce safe medication use behaviors and educate stakeholders on essential precautions. ProPharma's Contact Center Operations support REMS and RMP programs by serving as a central point of contact for patients and healthcare providers. We offer a globally accessible REMS/RMP services in, over 40 languages, adapting to local working hours and days. Our offerings include scalability, flexibility, and customizable options to support an expanding REMS portfolio. By partnering closely with our clients, we share best practices driving both innovation and efficiency. We are committed to service advancements through the use of technologies such as workforce management tools, digital communication channels (including chatbots and live chat), customer satisfaction surveys after calls, and automated line testing.
Inquiry Support
- Global Availability: ProPharma operates globally, offering support in all supported languages and aligning with local time zones.
- Multi-Channel Platforms: Provides assistance across various regions through phone, chat, email and other communication channels.
- Expert Management: Handles specific inquiries from healthcare providers and patients regarding risk management and minimization measures.
- Informed Decision-Making: Facilitates informed decision-making for healthcare providers.
- Comprehensive Resources: Maintains a repository of response documents and a comprehensive database of all submitted inquiries.
- Regular Reporting: Ensures consistent and detailed reporting.
- Compliance and Cultural Sensitivity: Complies with local legislation and adheres to local customs and cultures.

Product Access and Information
- Critical Product Access Information: Provides essential information to ensure access to critical products.
- Efficient Dissemination: Streamlines the distribution of RMP materials, both electronically and in hard copy.
- Pharmacy and Program Locator: Help locate pharmacies and programs that support access to REMS-required medications for patients.
- Patient Support: We offer assistance to patients facing financial or access barriers.

Adverse Event (AE) Management
- Adverse Event Identification and Intake: Our experienced team efficiently identifies and intakes adverse events. Specific REMS questionnaire can be completed at intake.
- Rapid Response: Quickly Identify and respond to safety concerns notifying these immediately to the client.
- Accurate Triage: Ensure precise triage and effective communication with relevant teams.
- Expedited Reporting: Adheres to accelerated AE reporting timelines.
- Post-AE Follow-Up: Conducts thorough follow-up after adverse events in the local language either in writing or via telephone.

Training and Education
- Educational Material Provision: Distributes educational materials to patients, including brochures, guides, and alert cards.
- Up-to-Date Information: Keeps healthcare providers and patients informed on the latest risk management strategies and guidelines.
- Compliance Reminders: Provides reminders and information on best practices to ensure compliance.
- Certification Verification: Evaluates and verifies healthcare providers’ certification in REMS or RMP.
- Educational Session Support: Facilitates registration and follow-up for educational sessions.

Our REMS and RMP Experts
-
Valerie Huh
Director, Global Innovation and Implementation
View Bio
-
Ana Ming
Senior Global Innovation and Implementation Manager
View Bio
Valerie Huh
Valerie Huh brings over 20 years of experience in the pharmaceutical and healthcare industries, with expertise in global operations and process improvements. She holds a Doctor of Pharmacy (Pharm.D.), a degree in Chemistry, and an MBA with a certificate in business analytics. In her current role, she leads innovation and technology enablement in Medical Information and supports business expansions, driving forward strategic initiatives to enhance service quality and operational efficiency.
Ana Ming
Ana Ming is a highly skilled pharmacist based in Australia, with 12+ years of experience in the pharmaceutical services and healthcare industries. Currently at ProPharma, she brings expertise in medical information management, patient care, and regulatory compliance. Additionally, Ana is a certified Justice of the Peace (JP), combining her healthcare experience with a commitment to community service and ethical leadership. Her collaborative approach, coupled with a focus on innovative solutions, makes her a valuable asset in optimizing patient outcomes and advancing pharmaceutical practices.
REMS & RMP Contact Center Support
Ensure safe medication practices and minimize risks with ProPharma’s REMS/RMP support services. Our globally accessible solutions provide expert assistance to patients and healthcare providers in over 40 languages, enhancing risk management through informed decisions and reliable communication channels.
News & Insights

October 2, 2025
Medical Information in the Netherlands: Safeguarding Compliance and Patient Conf...
Discover how ProPharma's medical information services in the Netherlands ensure patient safety, regulatory compliance, and data privacy with expert support.

September 30, 2025
Tips for Preparing Successful FDA 510(k) Submissions
Discover essential tips for preparing a successful FDA 510(k) submission. Learn common pitfalls to avoid, align with FDA expectations, and streamline your path to clearance.

July 8, 2025
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...
ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

October 6, 2025
Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel ...
When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, ProPharma stepped in —...
-chcecklist-complete-guide-fda-510k-submissions-ppg.png?width=320&height=185&name=510(k)-chcecklist-complete-guide-fda-510k-submissions-ppg.png)
September 30, 2025
Your Complete FDA 510(k) Premarket Notification Checklist
Step-by-step guide to navigating the FDA 510(k) submission process with confidence Submitting a 510(k) premarket notification is a critical milestone for medical device manufacturers seeking U.S....

November 18, 2025
Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions
Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

October 16, 2025
AI in Medical Information: Who Holds the Responsibility?
In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

September 25, 2025
Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy
Medical Information (MI) and Pharmacovigilance (PV) work together to protect public health by identifying and evaluating emerging safety signals. Watch our in-depth webinar, where our experts explore...
News & Insights

October 6, 2025
Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel ...
When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, ProPharma stepped in —...

November 18, 2025
Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions
Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

September 25, 2025
Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy
Medical Information (MI) and Pharmacovigilance (PV) work together to protect public health by identifying and evaluating emerging safety signals. Watch our in-depth webinar, where our experts explore...